Publication:
Assessment of synergistic interactions of danofloxacin and orbifloxacin against quinolone-resistant Escherichia coli isolated from animals by the checkerboard and time-kill methods

dc.contributor.buuauthorCengiz, Murat
dc.contributor.buuauthorŞahintürk, Pınar
dc.contributor.departmentVeterinerlik Fakültesi
dc.contributor.departmentFarmakoloji ve Toksikoloji Ana Bilim Dalı
dc.contributor.researcheridABE-5935-2020
dc.contributor.scopusid16635026700
dc.contributor.scopusid55342852700
dc.date.accessioned2023-05-09T10:52:38Z
dc.date.available2023-05-09T10:52:38Z
dc.date.issued2013-10
dc.description.sponsorshipEuropean Cooperation in Science and Technology (COST) (BM0701 ATENS')
dc.identifier.citationCengiz, M. ve Şahintürk, P. (2013). “Assessment of synergistic interactions of danofloxacin and orbifloxacin against quinolone-resistant Escherichia coli isolated from animals by the checkerboard and time-kill methods”. Journal of Antibiotics, 66(10), 629-631.
dc.identifier.endpage631
dc.identifier.issn0021-8820
dc.identifier.issue10
dc.identifier.pubmed23778116
dc.identifier.scopus2-s2.0-84886771418
dc.identifier.startpage629
dc.identifier.urihttps://doi.org/10.1038/ja.2013.62
dc.identifier.urihttp://hdl.handle.net/11452/32595
dc.identifier.volume66
dc.identifier.wos000326287600008
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherSpringernature
dc.relation.journalJournal of Antibiotics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.relation.tubitakTOVAG-110O478
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectBiotechnology & applied microbiology
dc.subjectImmunology
dc.subjectMicrobiology
dc.subjectPharmacology & pharmacy
dc.subjectDanofloxacin
dc.subjectEscherichia coli
dc.subjectOrbifloxacin
dc.subjectSynergism
dc.subjectIn-vitro
dc.subjectFloroquinolone resistance
dc.subjectPseudomonas-aeruginosa
dc.subjectCiprofloxacin
dc.subjectEnrofloxacin
dc.subjectCombination
dc.subjectMevhanisms
dc.subject.emtreeDanofloxacin
dc.subject.emtreeOrbifloxacin
dc.subject.emtreeAntibiotic resistance
dc.subject.emtreeArticle
dc.subject.emtreeBacterial strain
dc.subject.emtreeBactericidal activity
dc.subject.emtreeBacterium isolate
dc.subject.emtreeBacterium isolation
dc.subject.emtreeDrug efficacy
dc.subject.emtreeDrug potentiation
dc.subject.emtreeEscherichia coli
dc.subject.emtreeMinimum inhibitory concentration
dc.subject.emtreeNonhuman
dc.subject.emtreePriority journal
dc.subject.emtreeQuinolone resistant Escherichia coli
dc.subject.meshAnimals
dc.subject.meshAnti-bacterial agents
dc.subject.meshCiprofloxacin
dc.subject.meshDrug resistance, bacterial
dc.subject.meshDrug synergism
dc.subject.meshDrug therapy, combination
dc.subject.meshEscherichia coli
dc.subject.meshFluoroquinolones
dc.subject.meshMicrobial sensitivity tests
dc.subject.meshQuinolones
dc.subject.scopusEscherichia Coli; Plasmids; Enterobacteriaceae
dc.subject.wosBiotechnology & applied microbiology
dc.subject.wosImmunology
dc.subject.wosMicrobiology
dc.subject.wosPharmacology & pharmacy
dc.titleAssessment of synergistic interactions of danofloxacin and orbifloxacin against quinolone-resistant Escherichia coli isolated from animals by the checkerboard and time-kill methods
dc.typeArticle
dc.wos.quartileQ3
dc.wos.quartileQ4 (Immunology)
dspace.entity.typePublication
local.contributor.departmentVeterinerlik Fakültesi/Farmakoloji ve Toksikoloji Ana Bilim Dalı
local.indexed.atScopus
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: